Overview

A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder

Status:
Completed
Trial end date:
2021-04-13
Target enrollment:
Participant gender:
Summary
This trial is a 52-week study to assess the safety of long-term use of brexpiprazole as adjunctive therapy in combination with an antidepressant.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Brexpiprazole